Development of inflammatory bowel disease during anti-TNF-α therapy for inflammatory rheumatic disease: a nationwide series.

Toussirot, Éric

Development of inflammatory bowel disease during anti-TNF-α therapy for inflammatory rheumatic disease: a nationwide series. [electronic resource] - Joint bone spine Oct 2012 - 457-63 p. digital

Publication Type: Journal Article

1778-7254

10.1016/j.jbspin.2011.10.001 doi


Adolescent
Adult
Aged
Aged, 80 and over
Antibodies, Monoclonal--therapeutic use
Antirheumatic Agents--therapeutic use
Arthritis, Juvenile--drug therapy
Arthritis, Psoriatic--drug therapy
Arthritis, Rheumatoid--drug therapy
Child
Colitis, Ulcerative--chemically induced
Crohn Disease--chemically induced
Etanercept
Female
Follow-Up Studies
France--epidemiology
Humans
Immunoglobulin G--therapeutic use
Incidence
Inflammatory Bowel Diseases--chemically induced
Infliximab
Male
Middle Aged
Receptors, Tumor Necrosis Factor--therapeutic use
Retrospective Studies
Rheumatic Diseases--drug therapy
Spondylitis, Ankylosing--drug therapy
Tumor Necrosis Factor-alpha--antagonists & inhibitors
Young Adult